Showing results (21-30 of 61) with videos related to
Sort By:
Pageof 7
Multidisciplinary Respiratory Medicine|January 10, 2022
Standard spirometry to assess emphysema in patients with chronic obstructive pulmonary disease: the Emphysema Severity Index (ESI)Roberto W Dal Negro, Matteo Paoletti, Massimo PistolesiTherapeutic Advances in Respiratory Disease|September 15, 2018
Fluticasone furoate/vilanterol 92/22 µg once a day: a 12-month study on outcomes in mild to moderate asthmaRoberto W Dal Negro, Luca Bonadiman, Paola TurcoMultidisciplinary Respiratory Medicine|May 6, 2021
The contribution of patients' lung function to the inspiratory airflow rate achievable through a DPIs' simulator reproducing different intrinsic resistance ratesRoberto W Dal Negro, Paola Turco, Massimiliano PoveroChildren (Basel, Switzerland)|December 23, 2023
Trend of Bronchial Hyperresponsiveness to Methacholine as a Cost Predictor of Mild-to-Moderate Asthma: A Twelve-Month Survey in TeenagersRoberto W Dal Negro, Paola Turco, Massimiliano PoveroMultidisciplinary Respiratory Medicine|October 21, 2022
Long-lasting dyspnoea in patients otherwise clinically and radiologically recovered from COVID pneumonia: a probe for checking persisting disorders in capillary lung volume as a causeRoberto W Dal Negro, Paola Turco, Massimiliano PoveroMultidisciplinary Respiratory Medicine|January 13, 2023
Nebivolol: an effective option against long-lasting dyspnoea following COVID-19 pneumonia - a pivotal double-blind, cross-over controlled studyRoberto W Dal Negro, Paola Turco, Massimiliano PoveroMultidisciplinary Respiratory Medicine|August 1, 2018
Correction to: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthmaRoberto W Dal Negro, Luca Bonadiman, Paola TurcoMultidisciplinary Respiratory Medicine|June 28, 2018
Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthmaRoberto W Dal Negro, Luca Bonadiman, Paola TurcoMultidisciplinary Respiratory Medicine|September 19, 2019
Patients' usability of seven most used dry-powder inhalers in COPDRoberto W Dal Negro, Paola Turco, Massimiliano PoveroMultidisciplinary Respiratory Medicine|June 4, 2024
mRNA vaccines protect from the lung microvasculature injury and the capillary blood volume loss occurring in SARS-CoV-2 paucisymptomatic infectionsRoberto W Dal Negro, Paola Turco, Massimiliano PoveroPageof 7